The allegations read: Respondent was named in customer's complaint that asserted the following causes of action:
unauthorized trading, breach of fiduciary duty, churning, manipulation, misrepresentation, suitability, failure to supervise, negligence, indemnification, theft, recovery of commissions, swindle, and forgery. The causes of action related to claimant's allegations that respondents purchased shares in his account and traded on margin without his permission. Claimant further alleged that respondents falsified account documents to allow for trading other than the single purchase of fibrocell science stock, which he had authorized.
